Clinical Trial Update: A Study to Investigate IGT-303 in Healthy Volunteers and Participants With Chronic Kidney Disease [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update announcing the investigation of IGT-303 in healthy volunteers and individuals with chronic kidney disease, spanning Phase 1 and Phase 2, a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• IGT-303

Snippet

Sponsor: Ingenia Therapeutics INC | Conditions: Healthy Volunteers, Chronic Kidney Disease | Phase 1, Phase 2 | Status: RECRUITING